PO.5.105 The effect of belimumab on extra-renal outcomes: results from the phase 3, randomised, placebo-controlled, 104-week bliss-ln study in patients with active lupus nephritis
DOI
オープンアクセス
収録刊行物
-
- Friday 07 October 2022 from 13:00 to 14:10
-
Friday 07 October 2022 from 13:00 to 14:10 A83-A84, 2022-09-27
Lupus Foundation of America